Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H6ClNO3S |
| Molecular Weight | 159.592 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(=O)(=O)CCNCl
InChI
InChIKey=NMMHHSLZJLPMEG-UHFFFAOYSA-N
InChI=1S/C2H6ClNO3S/c3-4-1-2-8(5,6)7/h4H,1-2H2,(H,5,6,7)
| Molecular Formula | C2H6ClNO3S |
| Molecular Weight | 159.592 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:09:27 GMT 2025
by
admin
on
Mon Mar 31 19:09:27 GMT 2025
|
| Record UNII |
S3ZHQ09WZ5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C043410
Created by
admin on Mon Mar 31 19:09:27 GMT 2025 , Edited by admin on Mon Mar 31 19:09:27 GMT 2025
|
PRIMARY | |||
|
108018
Created by
admin on Mon Mar 31 19:09:27 GMT 2025 , Edited by admin on Mon Mar 31 19:09:27 GMT 2025
|
PRIMARY | |||
|
S3ZHQ09WZ5
Created by
admin on Mon Mar 31 19:09:27 GMT 2025 , Edited by admin on Mon Mar 31 19:09:27 GMT 2025
|
PRIMARY | |||
|
51036-13-6
Created by
admin on Mon Mar 31 19:09:27 GMT 2025 , Edited by admin on Mon Mar 31 19:09:27 GMT 2025
|
PRIMARY | |||
|
DB06633
Created by
admin on Mon Mar 31 19:09:27 GMT 2025 , Edited by admin on Mon Mar 31 19:09:27 GMT 2025
|
PRIMARY | |||
|
DTXSID80199047
Created by
admin on Mon Mar 31 19:09:27 GMT 2025 , Edited by admin on Mon Mar 31 19:09:27 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Being a mild oxidant, NCT proved to be very well tolerated by human tissue in Phase I and II clinical studies. A 1% aqueous solution can be applied to the eye, skin ulcerations, outer ear canal, nasal and paranasal sinuses, oral cavity and urinary bladder, and can probably be used for inhalation. Therapeutic efficacy in Phase II studies has been shown in external otitis, purulently coated crural ulcerations and keratoconjunctivitis, so far. Based upon all presently available data, NCT seems to be an antiseptic with a very good relation between tolerability and activity.
|
